EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Financial Statement Details
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ HISAMITSU PHARMACEUTICAL +
@ 関西ペイント +
@ The Nippon Synthetic Chemical Industry +
@ DAIICHI SANKYO +
@ 大正製薬ホールディングス +
@ NIHON NOHYAKU +
@ Shin-Etsu Chemical +
@ Fuso Pharmaceutical Industries +
@ 中外製薬 +
@ Kao +
@ JSR +
@ 富士製薬工業 +
@ アステラス製薬 +
@ エスケー化研 +
@ Nihon Parkrizing +
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-03 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
KIKUSUI ELECTRONICS etc.
graph
KIKUSUI ELECTRONICS etc.
graph
Hitachi Zosen etc.
graph
NIPPON COKE & ENGINEERING
graph
Nissan Motor
graph

Financial Statement Details: TAISHO PHARMACEUTICAL (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

*Free Download Financial Statement data

U-Chart(pie chart)2009-03-312010-03-312011-03-31
  • Cash etc.
  • Other Current Assets
  • Tangible Assets
  • Intangible Assets
  • Investment etc.
  • Current Liabilities
  • Fixed Liabilities
  • Capital stock
  • Capital surplus etc.
*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
[BS] 2009-03-31
 *  Total: ¥ 591 B
 *  Net: ¥ 514 B
 (Ratio: 86.97%)
[BS] 2010-03-31
 *  Total: ¥ 606 B
 *  Net: ¥ 527 B
 (Ratio: 87.03%)
[BS] 2011-03-31
 *  Total: ¥ 618 B
 *  Net: ¥ 535 B
 (Ratio: 86.55%)
Financial Statement Details2009-03-312010-03-312011-03-31
Cash etc. ¥ 112 B ¥ 105 B ¥ 133 B
Other Current Assets ¥ 102 B ¥ 110 B ¥ 99 B
Tangible Assets ¥ 92 B ¥ 90 B ¥ 90 B
Intangible Assets ¥ 10 B ¥ 34 B ¥ 30 B
Investment etc. ¥ 272 B ¥ 265 B ¥ 264 B
Total Assets ¥ 591 B ¥ 606 B ¥ 618 B
Current Liabilities ¥ 54 B ¥ 55 B ¥ 59 B
Fixed Liabilities ¥ 22 B ¥ 23 B ¥ 23 B
Capital stock ¥ 29 B ¥ 29 B ¥ 29 B
Capital surplus etc. ¥ 484 B ¥ 497 B ¥ 505 B
Liabilities and net assets ¥ 591 B ¥ 606 B ¥ 618 B
U-Chart(pie chart)2009-03-312010-03-312011-03-31
  • Sales
  • Cost of Sales
  • Other income
  • SG&A
  • Other expenses
  • Net income
*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
[PL] 2009-03-31
 *  Sales: ¥ 256 B
 *  Income: ¥ 8 B
 (Ratio: 3.44%)
[PL] 2010-03-31
 *  Sales: ¥ 258 B
 *  Income: ¥ 19 B
 (Ratio: 7.54%)
[PL] 2011-03-31
 *  Sales: ¥ 268 B
 *  Income: ¥ 34 B
 (Ratio: 12.99%)
Financial Statement Details2009-03-312010-03-312011-03-31
Sales ¥ 256 B ¥ 258 B ¥ 268 B
Cost of Sales ¥ 86 B ¥ 91 B ¥ 96 B
Gross profit ¥ 169 B ¥ 166 B ¥ 172 B
Other income ¥ 12 B ¥ 6 B ¥ 10 B
SG&A ¥ 131 B ¥ 132 B ¥ 128 B
Other expenses ¥ 40 B ¥ 20 B ¥ 18 B
Net income ¥ 8 B ¥ 19 B ¥ 34 B
U-Chart(pie chart)2009-03-312010-03-312011-03-31
  • Operating CF
  • Investment CF
  • Financial CF
  • Foreign Exchange Effects
  • Net Change in Cash
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
[CF] 2009-03-31
 *  OCF: ¥ 35 B
 *  Cash: ¥ -7 B
[CF] 2010-03-31
 *  OCF: ¥ 39 B
 *  Cash: ¥ +32 B
[CF] 2011-03-31
 *  OCF: ¥ 46 B
 *  Cash: ¥ +26 B
Financial Statement Details2009-03-312010-03-312011-03-31
Operating CF ¥ 35 B ¥ 39 B ¥ 46 B
Investment CF ¥ -12 B ¥ 11 B ¥ -792 M
Financial CF ¥ -29 B ¥ -18 B ¥ -18 B
Foreign Exchange Effects ¥ -1 B ¥ 212 M ¥ -677 M
Net Change in Cash ¥ -7 B ¥ 32 B ¥ 26 B
U-Chart(pie chart)2009-03-312010-03-312011-03-31
  • Issuance of new shares
  • Dividends from surplus
  • Net income
  • Purchase of treasury stock
  • Other Change in Stockholders Equity
  • Other Change in Net Assets
  • Net Change in Net Assets
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
[SS] 2009-03-31
 *  Income: ¥ 8 B
 *  Net: ¥ -34 B
[SS] 2010-03-31
 *  Income: ¥ 19 B
 *  Net: ¥ +13 B
[SS] 2011-03-31
 *  Income: ¥ 34 B
 *  Net: ¥ +7 B
Financial Statement Details2009-03-312010-03-312011-03-31
Issuance of new shares - - -
Dividends from surplus ¥ -7 B ¥ -7 B ¥ -7 B
Net income ¥ 8 B ¥ 19 B ¥ 34 B
Purchase of treasury stock ¥ -16 B ¥ -7 B ¥ -16 B
Other Change in Stockholders Equity ¥ -1 M - ¥ -1 M
Other Change in Net Assets ¥ -18 B ¥ 9 B ¥ -3 B
Net Change in Net Assets ¥ -34 B ¥ 13 B ¥ 7 B
U-Chart(pie chart)2009-03-312010-03-312011-03-31
  • Cash etc.
  • Other Current Assets
  • Tangible Assets
  • Intangible Assets
  • Investment etc.
  • Current Liabilities
  • Fixed Liabilities
  • Capital stock
  • Capital surplus etc.
*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
[BS] 2009-03-31
 *  Total: ¥ 576 B
 *  Net: ¥ 521 B
 (Ratio: 90.62%)
[BS] 2010-03-31
 *  Total: ¥ 589 B
 *  Net: ¥ 535 B
 (Ratio: 90.96%)
[BS] 2011-03-31
 *  Total: ¥ 596 B
 *  Net: ¥ 540 B
 (Ratio: 90.58%)
Financial Statement Details2009-03-312010-03-312011-03-31
Cash etc. ¥ 86 B ¥ 72 B ¥ 96 B
Other Current Assets ¥ 83 B ¥ 91 B ¥ 77 B
Tangible Assets ¥ 81 B ¥ 78 B ¥ 78 B
Intangible Assets ¥ 7 B ¥ 19 B ¥ 16 B
Investment etc. ¥ 316 B ¥ 327 B ¥ 327 B
Total Assets ¥ 576 B ¥ 589 B ¥ 596 B
Current Liabilities ¥ 36 B ¥ 34 B ¥ 37 B
Fixed Liabilities ¥ 17 B ¥ 18 B ¥ 18 B
Capital stock ¥ 29 B ¥ 29 B ¥ 29 B
Capital surplus etc. ¥ 492 B ¥ 506 B ¥ 510 B
Liabilities and net assets ¥ 576 B ¥ 589 B ¥ 596 B
U-Chart(pie chart)2009-03-312010-03-312011-03-31
  • Sales
  • Cost of Sales
  • Other income
  • SG&A
  • Other expenses
  • Net income
*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
[PL] 2009-03-31
 *  Sales: ¥ 198 B
 *  Income: ¥ 11 B
 (Ratio: 5.97%)
[PL] 2010-03-31
 *  Sales: ¥ 195 B
 *  Income: ¥ 21 B
 (Ratio: 11.24%)
[PL] 2011-03-31
 *  Sales: ¥ 197 B
 *  Income: ¥ 29 B
 (Ratio: 15.20%)
Financial Statement Details2009-03-312010-03-312011-03-31
Sales ¥ 198 B ¥ 195 B ¥ 197 B
Cost of Sales ¥ 67 B ¥ 67 B ¥ 65 B
Gross profit ¥ 131 B ¥ 128 B ¥ 131 B
Other income ¥ 10 B ¥ 7 B ¥ 8 B
SG&A ¥ 99 B ¥ 100 B ¥ 95 B
Other expenses ¥ 30 B ¥ 13 B ¥ 15 B
Net income ¥ 11 B ¥ 21 B ¥ 29 B
U-Chart(pie chart)2009-03-312010-03-312011-03-31
  • Issuance of new shares
  • Dividends from surplus
  • Net income
  • Purchase of treasury stock
  • Other Change in Stockholders Equity
  • Other Change in Net Assets
  • Net Change in Net Assets
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
[SS] 2009-03-31
 *  Income: ¥ 11 B
 *  Net: ¥ -25 B
[SS] 2010-03-31
 *  Income: ¥ 21 B
 *  Net: ¥ +13 B
[SS] 2011-03-31
 *  Income: ¥ 29 B
 *  Net: ¥ +4 B
Financial Statement Details2009-03-312010-03-312011-03-31
Issuance of new shares - - -
Dividends from surplus ¥ -7 B ¥ -7 B ¥ -7 B
Net income ¥ 11 B ¥ 21 B ¥ 29 B
Purchase of treasury stock ¥ -16 B ¥ -7 B ¥ -16 B
Other Change in Stockholders Equity ¥ 1 M - ¥ -1 M
Other Change in Net Assets ¥ -12 B ¥ 7 B ¥ -1 B
Net Change in Net Assets ¥ -25 B ¥ 13 B ¥ 4 B

Consolidated :Balance sheet (Annual ) 2008-03-312009-03-312010-03-312011-03-31
   Cash and deposits¥ 127 B¥ 112 B¥ 105 B¥ 133 B
   Notes and accounts receivable-trade¥ 61 B¥ 61 B¥ 60 B¥ 65 B
    Short-term investment securities¥ 25 B¥ 2 B¥ 7 B
    Merchandise and finished goods¥ 12 B¥ 14 B¥ 12 B
     Raw materials and supplies¥ 7 B¥ 7 B¥ 7 B
     Work in process¥ 2 B¥ 2 B¥ 2 B
   Deferred tax assets¥ 7 B¥ 7 B¥ 7 B¥ 8 B
    Allowance for doubtful accounts¥ -236 M¥ -159 M¥ -149 M¥ -311 M
   Other¥ 2 B¥ 8 B¥ 10 B¥ 3 B
   Current assets¥ 249 B¥ 215 B¥ 215 B¥ 233 B
    Buildings and structures¥ 126 B¥ 126 B¥ 129 B¥ 129 B
     Accumulated depreciation and impairment loss¥ -78 B¥ -81 B¥ -85 B
     Buildings and structures, net¥ 51 B¥ 48 B¥ 47 B¥ 44 B
    Machinery, equipment and vehicles¥ 77 B¥ 78 B¥ 78 B¥ 79 B
     Accumulated depreciation and impairment loss¥ -68 B¥ -69 B¥ -71 B
     Machinery, equipment and vehicles, net¥ 11 B¥ 9 B¥ 8 B¥ 7 B
    Land¥ 29 B¥ 29 B¥ 30 B¥ 32 B
    Construction in progress¥ 167 M¥ 1 B¥ 292 M¥ 2 B
     Other¥ 30 B¥ 31 B¥ 33 B¥ 33 B
      Accumulated depreciation and impairment loss¥ -27 B¥ -29 B¥ -30 B
      Other, net¥ 4 B¥ 4 B¥ 3 B¥ 3 B
    Property, plant and equipment¥ 97 B¥ 92 B¥ 90 B¥ 90 B
    Right of trademark¥ 3 B¥ 2 B¥ 4 B¥ 3 B
    Software¥ 3 B¥ 4 B¥ 4 B¥ 3 B
    Goodwill¥ 15 B¥ 2 B¥ 14 B¥ 13 B
     Other¥ 197 M¥ 166 M¥ 376 M¥ 369 M
    Intangible assets¥ 22 B¥ 10 B¥ 34 B¥ 30 B
     Investment securities¥ 216 B¥ 205 B¥ 202 B¥ 198 B
     Stocks of subsidiaries and affiliates¥ 29 B¥ 46 B¥ 47 B¥ 50 B
     Long-term prepaid expenses¥ 1 B¥ 1 B¥ 996 M¥ 998 M
     Deferred tax assets¥ 4 B¥ 14 B¥ 10 B¥ 10 B
     Other¥ 4 B¥ 5 B¥ 4 B¥ 4 B
      Allowance for doubtful accounts¥ -320 M¥ -302 M¥ -225 M¥ -198 M
    Investments and other assets¥ 257 B¥ 272 B¥ 265 B¥ 264 B
   Noncurrent assets¥ 377 B¥ 375 B¥ 390 B¥ 385 B
  Assets¥ 627 B¥ 591 B¥ 606 B¥ 618 B
   Notes and accounts payable-trade¥ 20 B¥ 20 B¥ 22 B¥ 25 B
   Accrued expenses¥ 7 B¥ 7 B¥ 7 B¥ 8 B
    Provision for bonuses¥ 4 B¥ 4 B¥ 4 B¥ 4 B
    Provision for sales returns¥ 773 M¥ 635 M¥ 545 M¥ 486 M
    Accounts payable-other¥ 12 B¥ 11 B¥ 10 B¥ 11 B
    Income taxes payable¥ 9 B¥ 9 B¥ 7 B¥ 8 B
    Short-term loans payable¥ 260 M¥ 605 M¥ 1 B¥ 235 M
   Other¥ 577 M¥ 624 M¥ 957 M¥ 717 M
   Current liabilities¥ 55 B¥ 54 B¥ 55 B¥ 59 B
    Provision for retirement benefits¥ 15 B¥ 15 B¥ 16 B¥ 17 B
    Provision for directors' retirement benefits¥ 1 B¥ 1 B¥ 1 B¥ 1 B
    Deferred tax liabilities¥ 740 M¥ 424 M¥ 529 M¥ 476 M
    Other¥ 4 B¥ 4 B¥ 4 B¥ 4 B
   Noncurrent liabilities¥ 22 B¥ 22 B¥ 23 B¥ 23 B
  Liabilities¥ 78 B¥ 77 B¥ 78 B¥ 83 B
   Capital stock¥ 29 B¥ 29 B¥ 29 B¥ 29 B
    Capital surplus¥ 14 B¥ 14 B¥ 14 B¥ 14 B
    Retained earnings¥ 534 B¥ 535 B¥ 506 B¥ 533 B
   Treasury stock¥ -46 B¥ -63 B¥ -30 B¥ -46 B
   Shareholders' equity¥ 532 B¥ 516 B¥ 520 B¥ 531 B
   Valuation difference on available-for-sale securities¥ 9 B¥ -3 B¥ 4 B¥ 1 B
   Foreign currency translation adjustment¥ -2 B¥ -8 B¥ -7 B¥ -9 B
   Valuation and translation adjustments¥ 7 B¥ -11 B¥ -3 B¥ -7 B
  Minority interests¥ 8 B¥ 9 B¥ 10 B¥ 10 B
  Net assets¥ 548 B¥ 514 B¥ 527 B¥ 535 B
 Liabilities and net assets¥ 627 B¥ 591 B¥ 606 B¥ 618 B
    Long-term loans payable¥ 1 B¥ 1 B
   Deferred gains or losses on hedges¥ -14 M
   Inventories¥ 24 B
     Accumulated depreciation¥ -74 B¥ -78 B
     Accumulated depreciation¥ -66 B¥ -68 B
      Accumulated depreciation¥ -26 B¥ -27 B
Consolidated :Income statement (Annual ) 2008-03-312009-03-312010-03-312011-03-31
   Net sales¥ 249 B¥ 256 B¥ 258 B¥ 268 B
   Cost of sales¥ 85 B¥ 86 B¥ 91 B¥ 96 B
    Selling, general and administrative expenses¥ 127 B¥ 131 B¥ 132 B¥ 128 B
 Gross profit¥ 164 B¥ 169 B¥ 166 B¥ 172 B
  Gross profit-net¥ 164 B¥ 169 B¥ 166 B¥ 172 B
   Provision for sales returns¥ 761 M¥ 635 M¥ 545 M¥ 486 M
   Reversal of provision for sales returns¥ 889 M¥ 773 M¥ 622 M¥ 552 M
 Operating income¥ 36 B¥ 37 B¥ 34 B¥ 44 B
  Interest income¥ 4 B¥ 4 B¥ 5 B¥ 5 B
  Dividends income¥ 1 B¥ 1 B¥ 941 M¥ 1 B
  Equity in earnings of affiliates¥ 3 B
  Real estate rent¥ 102 M¥ 35 M¥ 29 M¥ 40 M
  Other¥ 448 M¥ 1 B¥ 810 M¥ 528 M
  Non-operating income¥ 6 B¥ 6 B¥ 6 B¥ 10 B
  Interest expenses¥ 13 M¥ 35 M¥ 28 M¥ 8 M
  Equity in losses of affiliates¥ 487 M¥ 4 B¥ 3 B
  Commission fee¥ 303 M
  Other¥ 776 M¥ 386 M¥ 903 M¥ 84 M
  Non-operating expenses¥ 1 B¥ 5 B¥ 4 B¥ 453 M
 Ordinary income¥ 41 B¥ 39 B¥ 36 B¥ 54 B
  Gain on sales of noncurrent assets¥ 178 M¥ 4 M¥ 15 M¥ 7 M
  Gain on sales of investment securities¥ 59 M¥ 82 M
  Extraordinary income¥ 236 M¥ 5 B¥ 15 M¥ 90 M
  Impairment loss¥ 646 M¥ 523 M
  Loss on disaster¥ 1 B
  Loss on disposal of noncurrent assets¥ 453 M¥ 85 M¥ 104 M¥ 51 M
  Loss on valuation of investment securities¥ 19 M¥ 3 B¥ 268 M¥ 35 M
  Extraordinary loss¥ 1 B¥ 18 B¥ 896 M¥ 1 B
 Income before income taxes¥ 40 B¥ 26 B¥ 35 B¥ 53 B
 Income taxes¥ 15 B¥ 16 B¥ 15 B¥ 17 B
  Income taxes-current¥ 14 B¥ 17 B¥ 16 B¥ 16 B
  Income taxes-deferred¥ 1 B¥ -259 M¥ -1 B¥ 314 M
 Income before minority interests¥ 35 B
 Minority interests in income¥ 204 M¥ 1 B¥ 1 B¥ 901 M
 Net income¥ 25 B¥ 8 B¥ 19 B¥ 34 B
  Valuation difference on available-for-sale securities¥ -2 B
  Foreign currency translation adjustment¥ -2 B
  Share of other comprehensive income of associates accounted for using equity method¥ -286 M
  Other comprehensive income¥ -4 B
 Comprehensive income¥ 31 B
   Comprehensive income attributable to owners of the parent¥ 30 B
   Comprehensive income attributable to minority interests¥ 845 M
  Gain on sales of subsidiaries and affiliates' stocks¥ 4 B
  Gain on prior periods adjustment¥ 891 M
  Loss on change in equity¥ 2 B
    Advertising expenses¥ 14 B
    Welfare expenses¥ 5 B
    Depreciation¥ 4 B
    Provision of allowance for doubtful accounts¥ 16 M
    Provision for bonuses¥ 1 B
    Retirement benefit expenses¥ 1 B
    Research and development expenses¥ 24 B
    Salaries and bonuses¥ 24 B
    Rent expenses¥ 4 B
    Promotion expenses¥ 24 B
    Packing and transportation expenses¥ 7 B
    License fee¥ 1 B
    Transportation and communication expenses¥ 4 B
    Other¥ 8 B
  Reversal of allowance for doubtful accounts¥ 58 M
  Loss on sales of investment securities¥ 24 M
Consolidated :Cash flow statement (Annual ) 2008-03-312009-03-312010-03-312011-03-31
  Subtotal¥ 56 B¥ 47 B¥ 51 B¥ 57 B
   Depreciation and amortization¥ 12 B¥ 11 B¥ 11 B¥ 11 B
   Impairment loss¥ 646 M¥ 523 M
   Amortization of goodwill¥ 13 B¥ 281 M¥ 730 M
   Increase (decrease) in allowance for doubtful accounts¥ -114 M¥ -84 M¥ -87 M¥ 136 M
   Interest and dividends income¥ -5 B¥ -5 B¥ -5 B¥ -6 B
   Interest expenses¥ 13 M¥ 35 M¥ 28 M¥ 8 M
   Equity in (earnings) losses of affiliates¥ 487 M¥ 4 B¥ 3 B¥ -3 B
   Decrease (increase) in notes and accounts receivable-trade¥ 14 B¥ -589 M¥ 3 B¥ -4 B
   Decrease (increase) in inventories¥ -899 M¥ 1 B¥ -1 B¥ 575 M
   Increase (decrease) in notes and accounts payable-trade¥ -303 M¥ 153 M¥ 2 B¥ 2 B
   Loss (gain) on sales of investment securities¥ -82 M
   Increase (decrease) in provision for bonuses¥ 92 M¥ 37 M¥ 106 M¥ 65 M
   Increase (decrease) in provision for directors' retirement benefits¥ 54 M¥ -599 M¥ 55 M¥ 79 M
   Increase (decrease) in provision for retirement benefits¥ -1 B¥ 818 M¥ 847 M¥ 355 M
   Loss (gain) on valuation of investment securities¥ 19 M¥ 3 B¥ 268 M¥ 35 M
   Loss (gain) on sales of noncurrent assets¥ -178 M¥ -4 M¥ -15 M¥ -7 M
   Loss (gain) on disposal of noncurrent assets¥ 453 M¥ 85 M¥ 104 M¥ 51 M
   Decrease (increase) in prepaid pension costs¥ -1 B¥ -1 B¥ 32 M¥ -857 M
   Increase (decrease) in long-term accounts payable-other¥ -1 B¥ -229 M¥ -22 M¥ -58 M
   Other, net¥ -2 B¥ -2 B¥ -49 M¥ 2 B
  Interest and dividends income received¥ 6 B¥ 5 B¥ 5 B¥ 6 B
  Interest expenses paid¥ -13 M¥ -35 M¥ -28 M¥ -8 M
  Income taxes paid¥ -11 B¥ -17 B¥ -18 B¥ -16 B
  Net cash provided by (used in) operating activities¥ 50 B¥ 35 B¥ 39 B¥ 46 B
  Purchase of property, plant and equipment¥ -4 B¥ -3 B¥ -5 B¥ -7 B
  Proceeds from sales of property, plant and equipment¥ 718 M¥ 96 M¥ 47 M¥ 16 M
  Purchase of investment securities¥ -21 B¥ -64 B¥ -44 B¥ -15 B
  Proceeds from sales and redemption of securities¥ 3 B¥ 24 B¥ 2 B¥ 7 B
  Proceeds from sales and redemption of investment securities¥ 11 B¥ 47 B¥ 52 B¥ 16 B
  Purchase of intangible assets¥ -1 B¥ -1 B¥ -15 B¥ -557 M
  Proceeds from sales of intangible assets¥ 23 M¥ 8 M¥ 5 M
  Decrease (increase) in time deposits¥ 8 B¥ 5 B¥ 39 B¥ -638 M
  Proceeds from sales of investments in subsidiaries¥ 10 M
  Purchase of stocks of subsidiaries and affiliates¥ -10 B¥ -24 B¥ -4 B
  Purchase of long-term prepaid expenses¥ -515 M¥ -520 M¥ -405 M¥ -555 M
  Purchase of investments in subsidiaries resulting in change in scope of consolidation¥ -20 B¥ -13 B
  Other, net¥ -108 M¥ 580 M¥ 664 M¥ 156 M
  Net cash provided by (used in) investing activities¥ -35 B¥ -12 B¥ 11 B¥ -792 M
  Increase in short-term loans payable¥ 305 M¥ 645 M¥ 375 M¥ 285 M
  Decrease in short-term loans payable¥ -270 M¥ -265 M¥ -762 M¥ -275 M
  Repayment of long-term loans payable¥ -1 B
  Purchase of treasury stock¥ -938 M¥ -16 B¥ -7 B¥ -16 B
  Cash dividends paid¥ -11 B¥ -7 B¥ -7 B¥ -7 B
  Cash dividends paid to minority shareholders¥ -303 M¥ -357 M¥ -328 M
  Repayments of finance lease obligations¥ -103 M¥ -240 M¥ -267 M
  Net cash provided by (used in) financing activities¥ -11 B¥ -29 B¥ -18 B¥ -18 B
 Effect of exchange rate change on cash and cash equivalents¥ -10 M¥ -1 B¥ 212 M¥ -677 M
 Net increase (decrease) in cash and cash equivalents¥ 4 B¥ -7 B¥ 32 B¥ 26 B
 Cash and cash equivalents¥ 72 B¥ 64 B¥ 96 B¥ 123 B
   Loss (gain) on sales of stocks of subsidiaries and affiliates¥ -4 B
   Loss (gain) on change in equity¥ 2 B
  Purchase of investments in capital of subsidiaries¥ -494 M
  Proceeds from sales of stocks of subsidiaries and affiliates¥ 4 B
   Increase (decrease) in provision for directors' bonuses¥ -73 M
  Proceeds from long-term loans payable¥ 1 B
  Other, net-
Consolidated :Shareowners' equity (Annual ) 2008-03-312009-03-312010-03-312011-03-31
    Total changes of items during the period
     Total changes of items during the period
     Dividends from surplus¥ -11 B¥ -7 B¥ -7 B¥ -7 B
     Retirement of treasury stock¥ -40 B
     Total changes of items during the period¥ 13 B¥ 842 M¥ -28 B¥ 27 B
    Purchase of treasury stock¥ -938 M¥ -16 B¥ -7 B¥ -16 B
    Retirement of treasury stock¥ 40 B
    Change in equity in affiliates accounted for by equity method-treasury stock¥ -2 M¥ -6 M¥ -22 M
    Total changes of items during the period¥ -940 M¥ -16 B¥ 32 B¥ -16 B
    Dividends from surplus¥ -11 B¥ -7 B¥ -7 B¥ -7 B
    Net income¥ 25 B¥ 8 B¥ 19 B¥ 34 B
    Purchase of treasury stock¥ -938 M¥ -16 B¥ -7 B¥ -16 B
    Change in equity in affiliates accounted for by equity method-treasury stock¥ -2 M¥ -6 M¥ -22 M
    Total changes of items during the period¥ 12 B¥ -15 B¥ 3 B¥ 11 B
    Net changes of items other than shareholders' equity¥ -17 B¥ -13 B¥ 7 B¥ -2 B
    Total changes of items during the period¥ -17 B¥ -13 B¥ 7 B¥ -2 B
    Net changes of items other than shareholders' equity¥ -414 M¥ -5 B¥ 706 M¥ -2 B
    Total changes of items during the period¥ -414 M¥ -5 B¥ 706 M¥ -2 B
    Net changes of items other than shareholders' equity¥ -17 B¥ -19 B¥ 8 B¥ -4 B
    Total changes of items during the period¥ -17 B¥ -19 B¥ 8 B¥ -4 B
   Net changes of items other than shareholders' equity¥ 6 B¥ 771 M¥ 865 M¥ 517 M
   Total changes of items during the period¥ 6 B¥ 771 M¥ 865 M¥ 517 M
   Dividends from surplus¥ -11 B¥ -7 B¥ -7 B¥ -7 B
   Net income¥ 25 B¥ 8 B¥ 19 B¥ 34 B
   Purchase of treasury stock¥ -938 M¥ -16 B¥ -7 B¥ -16 B
   Change in equity in affiliates accounted for by equity method-treasury stock¥ -2 M¥ -6 M¥ -22 M
   Net changes of items other than shareholders' equity¥ -11 B¥ -18 B¥ 9 B¥ -3 B
   Total changes of items during the period¥ 1 B¥ -34 B¥ 13 B¥ 7 B
    Net changes of items other than shareholders' equity¥ 2 M¥ 14 M
    Total changes of items during the period¥ 2 M¥ 14 M

Free Download

*Free Download Financial Statement dataMember limited service.

[Data] Balance sheet, Income statement, Cash flow statement, Shareowners' equity (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: TAISHO PHARMACEUTICAL (Annual )

Statement Type
Annual : TAISHO PHARMACEUTICAL
First quarter : TAISHO PHARMACEUTICAL
Second quarter : TAISHO PHARMACEUTICAL
Third quarter : TAISHO PHARMACEUTICAL
Analysis Menu
@Outline : TAISHO PHARMACEUTICAL
@Statement : TAISHO PHARMACEUTICAL
@Rating : TAISHO PHARMACEUTICAL
@Indicator : TAISHO PHARMACEUTICAL
@Download : TAISHO PHARMACEUTICAL
Industry Comparison Ranking
Chemicals - EDIUNET Industry Rankings
Chemicals - EDIUNET Credit Rating
Chemicals - EDIUNET Industry Avg
Comparison with a neighboring company
Tokyo - EDIUNET Prefectures
Tokyo豊島区 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/23 Milbon AA→AAA 2013-12-20
1/17 Kawaguchi Chemical Indu.. BBB→BB 2013-11-30
1/17 SANKEI CHEMICAL A 2013-11-30
1/15 HOKKO CHEMICAL INDUSTRY BB→B 2013-11-30
1/15 Daito Pharmaceutical Co . AA 2013-11-30 (Q2)
1/15 KAWAKAMI PAINT MFG. B→BB 2013-11-30
1/15 旭化学工業 AA 2013-11-30 (Q1)
1/10 OSAKA ORGANIC CHEMICAL .. BB→BBB 2013-11-30
1/10 HISAMITSU PHARMACEUTICAL A 2013-11-30 (Q3)
1/10 AMS Life Science BBB→BB 2013-11-30 (Q1)

Ticker Market Industry Month report Rating
@ TAISHO PHARMACEUTICAL 4535 TSE 1st Chemicals 3 Annual AAA

Related Company

@ Mitsubishi Tanabe Pharma (Sales ¥ 419 B) +
@ TSUMURA & CO. (Sales ¥ 105 B) +
@ エスケー化研 (Sales ¥ 82 B) +
@ Nihon Parkrizing (Sales ¥ 89 B) +
@ 大正製薬ホールディングス (Sales ¥ 285 B) +
@ 塩野義製薬 (Sales ¥ 282 B) +
@ Fuso Pharmaceutical Industries (Sales ¥ 48 B) +
@ Shin-Etsu Chemical (Sales ¥ 1.0 T) +
@ アステラス製薬 (Sales ¥ 1.0 T) +
@ The Nippon Synthetic Chemical Industry (Sales ¥ 91 B) +
@ HISAMITSU PHARMACEUTICAL (Sales ¥ 142 B) +
@ 中外製薬 (Sales ¥ 391 B) +
@ Kuraray (Sales ¥ 369 B) +

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.116 sec.)